CELESTE CARNES: Open Payments
NPI 1275527376 · MEXICO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$769 in 41 payments from 12 companies in 2025. Trend: 2023 $531 · 2024 $681 · 2025 $769
Food & beverage: $769
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $180 |
| Novo Nordisk Inc | 9 | $168 |
| AstraZeneca Pharmaceuticals LP | 5 | $98 |
| Lilly USA, LLC | 4 | $76 |
| Merck Sharp & Dohme LLC | 3 | $62 |
| Exact Sciences Corporation | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Indivior Inc. | 1 | $23 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $19 |
Products named: VRAYLAR, Ozempic, AIRSUPRA, The Cologuard Plus Collection Kit, Wegovy, VERQUVO, ZEPBOUND, BREZTRI.
Industry payments across NY — which companies pay providers there.
